American Brain Tumor Association
Events Care & Support Donate Tumor Info About Us Home Home
January 2014

ABTA Tab

ABTA Honors Outstanding Medical Student Summer Fellow for 2013
The ABTA is pleased to announce Matthew D. Li as the recipient of the 2013 Lucien Rubinstein Award for his outstanding work in brain tumor research as an ABTA Medical Student Summer Fellow. Under the mentorship of Terry Burns, MD, PhD, and Theo Palmer, PhD, of Stanford University School of Medicine, Li's research focused on microglia and the chronic side effects of brain radiation therapy.

Upon completing his summer fellowship, Matthew stated, "My experience this summer as an ABTA Medical Student Summer Research Fellow has left a significant impact on me, teaching me countless practical research skills, sharpening my mind, and providing me an eye-opening perspective of the significant side effects of cancer therapies. I plan on pursuing a career in neuro-oncology, and this experience has solidified my motivation to work in this field." 

Li’s fellowship was supported by Dropping the Puck on Cancer at Indiana University, a fundraising event in support of the ABTA. To learn more about the ABTA's Medical Student Summer Fellowships and other research grant programs, click here.

 

Check Us Out in Impact
The ABTA was recently highlighted in Impact, the newsletter for the Dana-Farber Cancer Institute and The Jimmy Fund, for our research funding of young investigators. Click here to read the story (on page 7).
 

 

tab research news

Vascular Changes After Surgery for Brain Metastases
A recent research study found that patients undergoing surgery for brain metastases who had already received radiation to the brain experienced a greater number of stroke-related neurological deficits after surgery than those who had not previously received radiation. One hundred twenty-two patients (56 male, 66 female) were included in this study. This study, which appeared in the December 2013 Journal of Neurosurgery, suggests a high prevalence of vascular incidents in patients undergoing resection for metastatic brain disease. Click here to read the abstract.
 

Seizure Control Following Radiation Therapy
A study conducted in Italy showed that a high proportion of patients with difficult-to-control seizures from gliomas may experience a significant and durable reduction in their seizures following treatment with radiation. The study involved 43 patients (33 grade II tumors, 10 grade III tumors). The researchers report in December 2013 issue of Neuro-Oncology that 3 months after radiation, seizure frequency was reduced in 72% of the patients. At 12 months, seizures were reduced in 76% of patients. Click here to read the abstract.

 

Online Education Tab

Jill Barnholtz-Sloan

Webinar: “Causes and Risk Factors of Brain Tumors”
Wednesday, Feb. 12, 1:00-2:00 pm (Central time)
While no single risk factor accounting for the majority of brain tumors has yet to be identified, many studies have looked at a wide spectrum of environmental and genetic factors. This webinar will provide an update on what we know to be some causes and risk factors of brain tumors. The webinar will be presented by Jill Barnholtz-Sloan, PhD, associate professor at Case Comprehensive Cancer Center at the Case Western Reserve University School of Medicine, and will include a Q & A session with Dr. Barnholtz-Sloan.
Click here to register.



Dr Paul FisherWebinar: “Diagnosis, Management and Treatment of Medulloblastoma”
Thursday, Feb. 27, 2:00-3:00 pm (Central time)

Medulloblastoma is the most common brain tumor in children age four and younger and the second most common in children ages 5-14, accounting for 18% of all pediatric brain tumors. This webinar will provide the latest updates in the management and treatment of these challenging brain tumors. The webinar will be presented by Paul Fisher, MD, MHS, professor of Neurology and Pediatrics, and division chief of neurology at Stanford University Hospital and Lucile Salter Packard Children’s Hospital, and will include a Q & A session with Dr. Fisher.
Click here to register.
 

 

tab events

Start a Team and Make a Breakthrough in 2014
The Breakthrough for Brain Tumors 5K Run & Walk is a family-friendly event that allows people of all ages and athletic ability to support the mission of the ABTA. Gather friends, family, children, co-workers – anyone and everyone! – and join one of our 2014 events.

Visit www.bt5k.org or click on a city below to learn more.

ABTA Chi5K Team Resized

 

Move Further, Move Forward with Team Breakthrough
Challenge yourself to move further this year by participating in a full or half marathon with Team Breakthrough, the ABTA’s endurance team. Register for one of our partner races, listed below, with promo code RUNIN2014 and receive $25 off registration. Here’s where we’ll be racing this year:

todd mcdonald team breakthrough

You can also choose your own event - any distance, any race, any place. Learn more at www.abtateambreakthrough.org.

 

AboutABTA.gif
Founded in 1973, the American Brain Tumor Association was the first and is now the only national organization committed to funding brain tumor research and providing information, support and educational resources for all age groups and all  tumor types. For more information, visit www.abta.org or call 800-886-ABTA (2282).
 
Update Email Preferences | Forward to a Friend | Unsubscribe
©2014 American Brain Tumor Association  
The "American Brain Tumor Association" name and logo,  the "Breakthrough for Brain Tumors" name and logo, the "Team Breakthrough" name and logo and "TrialConnect" are registered trademarks of the American Brain Tumor Association. All rights reserved. 
 connections_new.JPG FaceBook trialconnect_icon.JPG Twitter [object Object] 

 

Having Fun Raising Funds
Join an Event Box

 

 

 

Read Headlines Online
FallWinter13-midsize.png

 

 

 

Connect with Others at Connections Online
ConnectionsHomepageNewFlash_July2011.JPG
links patients, families, friends and caregivers with each other for support and inspiration.
 

 

 

 

Find a Clinical Trial Through TrialConnect
TrialConnect.PNG
The ABTA's TrialConnect, a free and confidential service offered in English and Spanish.

 

 



ABTA_logo_new_notag_withtrade
For brain tumor information and support CALL OUR CARELINE: 800-886-ABTA (2282) or e-mail abtacares@abta.org

8550 W. Bryn Mawr Ave.
Suit 550
Chicago, IL 60631

Click here to support the American Brain Tumor Association.
Donate Now Button 

This communication is not intended as a substitute for professional medical advice and does not provide advice on treatments or conditions for individual patients. All health and treatment decisions must be made in consultation with your physician(s), utilizing your specific medical information. The links set out on this communication are provided for your convenience only. The American Brain Tumor Association does not endorse the information contained on the linked websites or individual(s)/companies/institutions operating these websites.